Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000904454-24-000538
Filing Date
2024-10-18
Accepted
2024-10-18 17:23:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 s13g_093024-rapportthera.htm SC 13G 50265
  Complete submission text file 0000904454-24-000538.txt   51920
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filed by) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 1229
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215 857-321-8020
Rapport Therapeutics, Inc. (Subject) CIK: 0002012593 (see all company filings)

EIN.: 880724208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94532 | Film No.: 241381506
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)